AI Networking Cookbook: Practical recipes for AI-assisted network automation and development
TL;DR
This article systematically reviews the endometrial cancer-related research presented at the 2026 SGO annual Meeting and provides a comprehensive analysis of research hotspots, unmet clinical needs, and future trends in this field.
This study systematically delineates the clinical research status and trends in bladder cancer (Bca) therapeutics through an analysis of 1024 Bca drug treatment clinical trials identified from a harmonised search of the Trialtrove database, ClinicalTrials.gov, and the World Health Organization International Clinical Tr...
The 22nd National Report on Clinical Trials of Medicinal Products published by the Italian Medicines Agency (AIFA) in July 2026 highlights contrasting trends in Italian clinical research. In 2024, 669 prospective clinical trials were authorized, the highest number recorded in the last three years. Oncology and hemato-o...
The 2026 American Society of Clinical Oncology (ASCO) Annual Meeting presented important advances in genitourinary oncology. During a resident-led Post-ASCO GU 2026 meeting supervised by genitourinary oncology experts, clinically relevant studies were selected and critically discussed. This report reviews PROTEUS and T...
BACKGROUND Ovarian, cervical and endometrial cancers have been the leading cause of morbidity and mortality in women, often resulting from late diagnosis, resistance to therapies and off-target toxicity of conventional therapies. DISCUSSION The review discusses recent progress in the development of dual-targeted nano...
Focusing on acquired resistance as a core bottleneck in precision therapy, mechanisms underlying anti-Human Epidermal Growth Factor Receptor 2 (HER2) resistance and primary/secondary resistance to immune checkpoint inhibitors (ICIs) were systematically dissected, while also addressing immune-related adverse events and...
Current data support the incorporation of tumor genomic analysis into routine clinical decision-making as an important step toward precision-based care in endometrial cancer, and suggest that molecular profiling may better identify patients who would benefit from treatment intensification or de-escalation compared with...
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.